Clinical work and continuous investigation have improved the outcome of critically ill patients over time. Nowadays, innovation pulled by demand and translational research projects of excellence will constitute new opportunities for clinicians to improve care and provide economic incentives to be returned to the patient, institutions, and society.

Over 60 years of clinical work and research in critical care medicine have improved survival in critically ill patients. This improvement is due to better treatment of disease in target organs and better treatment of problems such as sepsis, and also due to interdisciplinary approaches, early detection, and integrative information systems \[[@B1],[@B2]\]. Intensivists work with cutting-edge technologies limited by financial constraints, so the cost/efficiency of each ICU process is analyzed in detail \[[@B3]\]. However, epidemiologic research, physiologic research, and translational research have yielded mixed results. Despite notable advances, expensive large randomized clinical trials have yielded disappointing results in many areas. We must therefore reorient translation research and also exploit our knowledge to promote innovation studies that enable faster application in clinical practice. Innovation studies can lead to benefits for professionals, institutions, and society \[[@B4]\].

Opportunities for innovation in critical care abound. Critical care is personalized, and the patient is the key element. Since professionals and patients have pivotal roles, innovation will be pulled by demand. Interdisciplinary work with other medical or nonmedical disciplines can drive innovation. Programs to improve ventilated patients\' mobility would be impossible without the close collaboration of physical therapists, nurses, and related industry \[[@B5]\]. Likewise, designing and applying neurocognitive rehabilitation programs to prevent long-term sequelae require collaboration with informatics engineers and neuropsychologists \[[@B6],[@B7]\]. Huge amounts of data are stored in electronic records for each patient, and exploiting these data could lead to benefits. Integrative information systems can improve decision-making, as is evidenced by patient response to therapy based on the use of different monitoring devices \[[@B8]-[@B10]\]. Critical care is among the first places in the hospital to incorporate new technologies, providing opportunities to collaborate with the health industry in developing new products designed through common knowledge and to share final outputs and benefits. Knowledge resides in the clinical arena, so intensivists and their teams must be more than final users.

Instead of viewing critical care as a drain through which large proportions of limited resources disappear, we must consider these departments as opportunities for long-term economic growth. Innovation in public institutions must provide economic incentives to be returned to the patient, institutions, and society in terms of much better care. Intensivists face a new era in which old paradigms must be replaced with new business models; this path is full of uncertainties, but is very exciting \[[@B1],[@B2]\].
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